|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.910 USD | -1.55% |
|
-7.73% | -64.43% |
| 06-29 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 06-29 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
Company Valuation: Compass Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 309 | 633.5 | 198.8 | 199.5 | 955.1 | 344 | - | - |
| Change | - | 105.02% | -68.61% | 0.34% | 378.75% | -63.99% | - | - |
| Enterprise Value (EV) 1 | 309 | 633.5 | 198.8 | 72.78 | 955.1 | 194 | 212 | 266 |
| Change | - | 105.02% | -68.61% | -63.39% | 1,212.3% | -79.69% | 9.28% | 25.48% |
| P/E | -2.42x | -13.6x | -4.73x | -4.03x | -12.8x | -4.38x | -4.11x | -13.3x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | 0.4x | -0.44x | -0.8x | -1.15x | -0.63x | 0.2x |
| Capitalization / Revenue | - | - | - | 235x | - | -167x | 13.6x | 2.71x |
| EV / Revenue | - | - | - | 85.6x | - | -94.3x | 8.39x | 2.1x |
| EV / EBITDA | -3.8x | -15.5x | -4x | -1.3x | -13.2x | -2.21x | -2.24x | -2.95x |
| EV / EBIT | -3.77x | -15.2x | -3.95x | -1.29x | -13.1x | -2.25x | -2.29x | -8.54x |
| EV / FCF | -14.3x | - | - | -1.62x | -19.4x | -2.71x | -2.71x | -13.8x |
| FCF Yield | -6.98% | - | - | -61.7% | -5.15% | -36.9% | -36.9% | -7.27% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -0.37 | -0.33 | -0.36 | -0.42 | -0.436 | -0.4647 | -0.1433 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | 0.85 | - | -2.057 | 25.27 | 126.9 |
| EBITDA 1 | -81.32 | -40.87 | -49.66 | -56.04 | -72.56 | -87.6 | -94.75 | -90.29 |
| EBIT 1 | -81.88 | -41.66 | -50.36 | -56.62 | -72.84 | -86.22 | -92.52 | -31.14 |
| Net income 1 | -82.18 | -39.22 | -42.49 | -49.38 | -66.49 | -82.44 | -89.57 | -28 |
| Net Debt 1 | - | - | - | -126.7 | - | -150 | -132 | -78 |
| Reference price 2 | 3.170 | 5.030 | 1.560 | 1.450 | 5.370 | 1.910 | 1.910 | 1.910 |
| Nbr of stocks (in thousands) | 97,472 | 125,938 | 127,455 | 137,589 | 177,862 | 180,088 | - | - |
| Announcement Date | 3/18/22 A | 3/15/23 A | 3/21/24 A | 2/27/25 A | 3/5/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.38x | -94.29x | -2.21x | - | 344M | |
| 21.25x | 6.51x | 14.24x | 1.5% | 56.54B | |
| 31.6x | 7.8x | 24.02x | 0.05% | 53.6B | |
| -17.91x | 4.18x | -7.32x | -.--% | 22.91B | |
| -38.6x | 12.23x | -36.05x | -.--% | 21.37B | |
| 25.45x | 4.98x | 13.18x | -.--% | 20.27B | |
| 24.28x | 4.73x | 15.36x | -.--% | 17.56B | |
| -737.38x | 35.03x | -3943.97x | -.--% | 14.75B | |
| 40.7x | 16.37x | 42.16x | 0.09% | 13.53B | |
| 16.68x | 4.82x | 11.24x | -.--% | 13.33B | |
| Average | -63.83x | 0.24x | -386.94x | 0.18% | 23.42B | |
| Weighted average by Cap. | -32.03x | 8.96x | -238.04x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMPX Stock
- Valuation Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
